Co-Diagnostics's total assets for Q3 2024 were $72.38M, a decrease of -10.31% from the previous quarter. CODX total liabilities were $8.60M for the fiscal quarter, a 3.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.